OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular targets of psychedelic‐induced plasticity
Alaina M. Jaster, Mario de la Fuente Revenga, Javier González‐Maeso
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 80-88
Open Access | Times Cited: 22

Showing 22 citing articles:

Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 80

Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 3

Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response
I. Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113612-113612
Open Access | Times Cited: 53

Psychedelics and Neural Plasticity: Therapeutic Implications
Steven F. Grieco, Eero Ċastrén, Gitte M. Knudsen, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 45, pp. 8439-8449
Open Access | Times Cited: 45

Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30

Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice
Kenneth Alper, Janelle Cange, Ria Sah, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 27

Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 23

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16

Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9

Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
Mario de la Fuente Revenga, Alaina M. Jaster, John McGinn, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 16, pp. 2436-2448
Open Access | Times Cited: 33

Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
Alaina M. Jaster, Jason Younkin, Travis Cuddy, et al.
Neuroscience Letters (2022) Vol. 788, pp. 136836-136836
Open Access | Times Cited: 29

The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
Somdatta Saha, Javier González‐Maeso
Neuropharmacology (2023) Vol. 230, pp. 109489-109489
Open Access | Times Cited: 17

Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Giordano Novak Rossi, Lorena T. L. Guerra, Glen B. Baker, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1618-1618
Open Access | Times Cited: 17

Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review
Margery J.Q. Chen, David Chen‐Li, Noah Chisamore, et al.
Psychiatry Research (2025) Vol. 349, pp. 116532-116532
Open Access

Animal Behavior in Psychedelic Research
Anna U. Odland, Jesper L. Kristensen, Jesper T. Andreasen
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 1176-1205
Open Access | Times Cited: 12

Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice
Margareth Nogueira, Daiane C Ferreira Golbert, Richardson Menezes, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 2

Hallucinogenic activity, neurotransmitters release, anxiolytic and neurotoxic effects in Rat's brain following repeated administration of novel psychoactive compound 25B-NBOMe
Adam Wojtas, Monika Herian, Marzena Maćkowiak, et al.
Neuropharmacology (2023) Vol. 240, pp. 109713-109713
Closed Access | Times Cited: 5

Potential therapeutic use of ayahuasca: A literature review
Salvana Priscylla Manso Costa, Keith Cardoso CARVALHO, Isabella Nunes GOMES, et al.
Acta Amazonica (2024) Vol. 54, Iss. 2
Open Access

Classic psychedelics in translational research: addressing epistemic challenges from bench to bedside
Jaipreet Mattu, Jacqueline Sullivan
Oxford University Press eBooks (2024), pp. 141-165
Closed Access

THE SEROTONIN 5-HT2ARECEPTOR AS AN EVOLVING NEUROTHERAPEUTIC TARGET
Andrew A. Bolinger, Noelle C. Anastasio, Kathryn A. Cunningham, et al.
Medicinal chemistry reviews (2023), pp. 53-81
Closed Access

Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice
Margareth Nogueira, Daiane Ferreira Golbert, Richardson Menezes, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top